Healthcare & Life Sciences News and Articles

Google News – Biopharma External News

This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree - BioPharma Dive

news.google.com · 11 Sep 2026

Google News – Pharmaceuticals External News

Gregg Gorniak: What Changed in Five Years of DSCSA? - Pharmaceutical Commerce

news.google.com · 11 Sep 2026

Google News – Pharmaceuticals External News

Pharmaceutical-Grade Polyethylene Tubing Market Forecast to 2035: Single-Use Bioprocessing to Drive 6-9% CAGR - News and Statistics - IndexBox

news.google.com · 11 Sep 2026

Google News – Medical Devices External News

Nutromics’ drug monitoring patch secures FDA breakthrough designation - medicaldevice-network.com

news.google.com · 11 Sep 2026

Google News – Pharmaceuticals External News

If You Invested $100 In Alnylam Pharmaceuticals Stock 20 Years Ago, You Would Have This Much Today - benzinga.com

news.google.com · 11 Sep 2026

Google News – Pharmaceuticals External News

Sun Pharma Says Execution Of Settlement Agreement With A Plaintiff In The In Re Generic Pharmaceuticals Pricing Antitrust Litigation - TradingView

news.google.com · 11 Sep 2026

Google News – FDA (biotech/pharma) External News

Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11 - TradingView

news.google.com · 11 Sep 2026

Google News – Pharmaceuticals External News

Rx Rundown: GSK, Novartis, Ionis Pharmaceuticals and more - Medical Marketing and Media

news.google.com · 11 Sep 2026

Google News – Pharmaceuticals External News

BioCryst Pharmaceuticals: Why The Selloff Could Be An Opportunity (NASDAQ:BCRX) - Seeking Alpha

news.google.com · 11 Sep 2026

Google News – Biopharma External News

Helix BioPharma Stock Under Pressure: Bearish Momentum Raises Correction Risk as Investors Await Clinical Progress - kalkine.ca

news.google.com · 11 Sep 2026

Google News – FDA (biotech/pharma) External News

FDA delays approval decision for Exelixis' tyrosine kinase inhibitor in colorectal cancer - Fierce Biotech

news.google.com · 11 Sep 2026

Google News – Pharmaceuticals External News

X4 Pharmaceuticals (XFOR) Loses 20.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

news.google.com · 11 Sep 2026

Google News – Pharmaceuticals External News

Vanda Pharmaceuticals at Cantor conference: psychiatry push takes center stage - Investing.com

news.google.com · 11 Sep 2026

Google News – Pharmaceuticals External News

NRx Pharmaceuticals at Cantor conference: ketamine push gains momentum - Investing.com

news.google.com · 11 Sep 2026

Google News – Oncology External News

Cancer still dominates pharma R&D. Obesity is gaining ground. - pharmavoice.com

news.google.com · 11 Sep 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree - BioPharma Dive

Gregg Gorniak: What Changed in Five Years of DSCSA? - Pharmaceutical Commerce

Pharmaceutical-Grade Polyethylene Tubing Market Forecast to 2035: Single-Use Bioprocessing to Drive 6-9% CAGR - News and Statistics - IndexBox

Nutromics’ drug monitoring patch secures FDA breakthrough designation - medicaldevice-network.com

If You Invested $100 In Alnylam Pharmaceuticals Stock 20 Years Ago, You Would Have This Much Today - benzinga.com

Sun Pharma Says Execution Of Settlement Agreement With A Plaintiff In The In Re Generic Pharmaceuticals Pricing Antitrust Litigation - TradingView

Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11 - TradingView

Rx Rundown: GSK, Novartis, Ionis Pharmaceuticals and more - Medical Marketing and Media

BioCryst Pharmaceuticals: Why The Selloff Could Be An Opportunity (NASDAQ:BCRX) - Seeking Alpha

Helix BioPharma Stock Under Pressure: Bearish Momentum Raises Correction Risk as Investors Await Clinical Progress - kalkine.ca

FDA delays approval decision for Exelixis' tyrosine kinase inhibitor in colorectal cancer - Fierce Biotech

X4 Pharmaceuticals (XFOR) Loses 20.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Vanda Pharmaceuticals at Cantor conference: psychiatry push takes center stage - Investing.com

NRx Pharmaceuticals at Cantor conference: ketamine push gains momentum - Investing.com

Cancer still dominates pharma R&D. Obesity is gaining ground. - pharmavoice.com